Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Outstanding
Ratios

Dianthus Therapeutics (DNTH) Shares Outstanding: 2016-2024

Historic Shares Outstanding for Dianthus Therapeutics (DNTH) over the last 7 years, with Dec 2024 value amounting to $31.1 million.

  • Dianthus Therapeutics' Shares Outstanding rose 45.93% to $42.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.9 million, marking a year-over-year increase of 45.93%. This contributed to the annual value of $31.1 million for FY2024, which is 109.99% up from last year.
  • Per Dianthus Therapeutics' latest filing, its Shares Outstanding stood at $31.1 million for FY2024, which was up 109.99% from $14.8 million recorded in FY2023.
  • Dianthus Therapeutics' Shares Outstanding's 5-year high stood at $33.3 million during FY2022, with a 5-year trough of $14.8 million in FY2023.
  • Its 3-year average for Shares Outstanding is $26.4 million, with a median of $31.1 million in 2024.
  • As far as peak fluctuations go, Dianthus Therapeutics' Shares Outstanding tumbled by 55.55% in 2023, and later surged by 109.99% in 2024.
  • Yearly analysis of 3 years shows Dianthus Therapeutics' Shares Outstanding stood at $33.3 million in 2022, then tumbled by 55.55% to $14.8 million in 2023, then surged by 109.99% to $31.1 million in 2024.